Stockhub

TaiMed Biologics Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 September 2022

  • curprev 08:0708:07, 26 September 2022‎ 95.149.241.133 talk‎ 934 bytes +934‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; T..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/TaiMed_Biologics_Inc.’